Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN10A | Q9Y5Y9 | 18/20 | 0.41 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.38 |
| ▸ | MBOAT4 | Q96T53 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26608619 | 1.00 | SCN10A (0.41) | SCN10AADRB2MBOAT4 | |
| SCHEMBL30631474 | 0.90 | MBOAT4 (0.40) | SCN10AMBOAT4 | |
| SCHEMBL26615699 | 0.90 | MBOAT4 (0.40) | SCN10AMBOAT4 | |
| SCHEMBL26608368 | 0.84 | SCN10A (0.41) | SCN10AADRB2 | |
| SCHEMBL21906116 | 0.82 | SCN10A (0.52) | SCN10AADRB2MBOAT4 | |
| SCHEMBL26608348 | 0.81 | SCN10A (0.47) | SCN10A | |
| SCHEMBL31440798 | 0.79 | SCN10A (0.38) | SCN10AMBOAT4 | |
| SCHEMBL26615762 | 0.79 | SCN10A (0.38) | SCN10AMBOAT4 | |
| SCHEMBL26608301 | 0.78 | SCN10A (0.36) | SCN10AADRB2 | |
| SCHEMBL26608409 | 0.78 | SCN10A (0.47) | SCN10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119677737-A | Heteroaryl compounds for the treatment of pain | 沃泰克斯药物股份有限公司 | 2025-03-21 | — | — | CN | disclosed |
| CN-119546580-A | Heteroaryl compounds for the treatment of pain | 沃泰克斯药物股份有限公司 | 2025-02-28 | — | — | CN | disclosed |
| EP-4511116-A1 | HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN | Vertex Pharmaceuticals Incorporated (US) | 2025-02-26 | — | — | EP | disclosed |
| EP-4511115-A1 | HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN | Vertex Pharmaceuticals Incorporated (US) | 2025-02-26 | — | — | EP | disclosed |
| WO-2023205468-A1 | HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2023-10-26 | — | — | WO | disclosed |
| WO-2023205463-A1 | HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2023-10-26 | — | — | WO | disclosed |